View More Recent Stories
-
Option Care Health (OPCH) PT Raised to $35 at JMP Securities
-
Jefferies Upgrades Option Care Health (OPCH) to Buy
-
Option Care Health (OPCH) in the money January 25 calls as share price up 15%
-
BofA Securities Upgrades Option Care Health (OPCH) to Buy
-
Option Care Health (OPCH) Reports Prelim Q4 Results, Offers 2025 Guidance
-
UBS Starts Option Care Health (OPCH) at Neutral
-
Goldman Sachs Downgrades Option Care Health (OPCH) to Neutral
-
Option Care Health (OPCH) PT Lowered to $34 at Truist Securities
-
Option Care Health (OPCH) PT Lowered to $30 at Deutsche Bank
-
Jefferies Downgrades Option Care Health (OPCH) to Hold
-
BofA Securities Downgrades Option Care Health (OPCH) to Neutral
-
Option Care Health (OPCH) Trades Mid $28 Handle Down 1.5% Following Premarket Rise to $30
-
JMP Securities on Option Care Health (OPCH): 'competitor withdrawal as an intermediate- and longer-term positive'
-
Option Care Health (OPCH) Trades Flat Now Following Premarket Surge to $30
-
Deutsche Bank Reiterates Buy Rating on Option Care Health (OPCH)
-
Option Care Health (OPCH) Tops Q2 EPS by 2c, provides guidance
-
JMP Securities Starts Option Care Health (OPCH) at Market Outperform


